Safety and Demonstrated Efficacy of Placenta-Derived Cell Therapy PLX-R18 in Subjects with Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation: A Phase I International Multi-Center Study

Category Primary study
JournalBlood
Year 2020
This article has no abstract
Epistemonikos ID: b68fffde3e8f0453b8b633bd0d6e637600ec15b6
First added on: Feb 12, 2025